Examl 1:l NU665C/l NUl 665Cl (NEWl 2025/l
2026l Update)l Psychiatricl Mentall Healthl
Carel ofl thel Familyl IIl Review|l Questionsl
&l Answers|l Gradel A|l 100%l Correctl
(Verifiedl Solutions)-l Regis
QUESTION
Whichl factorl isl mostl predictivel ofl relapsel inl substancel usel disorder?
a)l Agel atl firstl use
b)l Previousl withdrawall symptoms
c)l Lengthl ofl abstinence
d)l Familyl historyl ofl substancel usel disorder
Answer:
Previousl withdrawall symptoms
QUESTION
Whichl ofl thel followingl isl al keyl featurel ofl deliriuml tremensl (DTs)?
a)l Mildl anxietyl andl insomnia
b)l Auditoryl andl visuall hallucinationsl withl autonomicl instability
c)l Opioidl cravingsl andl nausea
d)l Mildl withdrawall symptomsl resolvingl withinl 24l hours
Answer:
b)l Auditoryl andl visuall hallucinationsl withl autonomicl instability
QUESTION
Whichl pharmacologicall treatmentl isl FDA-approvedl forl bothl opioidl usel disorderl andl
alcoholl usel disorder?
a)l Methadone
b)l Disulfiram
c)l Naltrexone
d)l Acamprosate
,Answer:
c)l Naltrexone
QUESTION
Al 45-year-oldl womanl withl alcoholl usel disorderl isl admittedl tol thel hospitall withl
confusion,l ataxia,l andl ophthalmoplegia.l Whatl isl thel mostl likelyl diagnosis?
a)l Deliriuml tremens
b)l Wernicke'sl encephalopathy
c)l Korsakoff'sl syndrome
d)l Alcoholl withdrawall seizures
Answer:
(b)l Wernicke'sl encephalopathy
QUESTION
Al 22-year-oldl malel withl severel opioidl usel disorderl isl startedl onl medication-assistedl
treatmentl (MAT).l Whichl medicationl isl mostl appropriatel tol initiatel inl anl outpatientl
setting?
a)l Methadone
b)l Buprenorphine/Naloxone
c)l Naltrexone
d)l Disulfiram
Answer:
b)l Buprenorphine/Naloxone
QUESTION
Al patientl undergoingl opioidl withdrawall isl mostl likelyl tol exhibitl whichl symptom?
a)l Respiratoryl depression
b)l Mydriasis,l piloerection,l andl diarrhea
c)l Sedationl andl hypotension
d)l Bradycardial andl pinpointl pupils
Answer:
(b)l Mydriasis,l piloerection,l andl diarrhea
, QUESTION
Whichl screeningl tooll isl mostl appropriatel forl detectingl hazardousl alcoholl usel inl primaryl
carel settings?
a)l CAGE
b)l PHQ-9
c)l AUDIT-C
d)l GAD-7
Answer:
(c)l AUDIT-C
QUESTION
Whichl ofl thel followingl bestl differentiatesl substancel dependencel froml substancel abusel
inl DSM-5-TRl terminology?
a)l Dependencel isl characterizedl byl continuedl usel despitel negativel consequences,l whilel
abusel isl not.
b)l Dependencel includesl physiologicall withdrawall symptomsl andl tolerance,l whereasl
abusel doesl not.
c)l Therel isl nol distinctionl betweenl dependencel andl abusel inl DSM-5-TR;l theyl arel nowl
classifiedl asl Substancel Usel Disorder.
d)l Abusel involvesl withdrawall symptoms,l whereasl dependencel doesl not.
Answer:
(c)l Therel isl nol distinctionl betweenl dependencel andl abusel inl DSM-5-TR
QUESTION
Whichl neurotransmitterl systeml isl mostl directlyl involvedl inl thel reinforcingl effectsl ofl
substancel use?
a)l Serotonergicl system
b)l Dopaminergicl system
c)l Cholinergicl system
d)l GABAergicl system
Answer:
b)l Dopaminergicl system
QUESTION
2026l Update)l Psychiatricl Mentall Healthl
Carel ofl thel Familyl IIl Review|l Questionsl
&l Answers|l Gradel A|l 100%l Correctl
(Verifiedl Solutions)-l Regis
QUESTION
Whichl factorl isl mostl predictivel ofl relapsel inl substancel usel disorder?
a)l Agel atl firstl use
b)l Previousl withdrawall symptoms
c)l Lengthl ofl abstinence
d)l Familyl historyl ofl substancel usel disorder
Answer:
Previousl withdrawall symptoms
QUESTION
Whichl ofl thel followingl isl al keyl featurel ofl deliriuml tremensl (DTs)?
a)l Mildl anxietyl andl insomnia
b)l Auditoryl andl visuall hallucinationsl withl autonomicl instability
c)l Opioidl cravingsl andl nausea
d)l Mildl withdrawall symptomsl resolvingl withinl 24l hours
Answer:
b)l Auditoryl andl visuall hallucinationsl withl autonomicl instability
QUESTION
Whichl pharmacologicall treatmentl isl FDA-approvedl forl bothl opioidl usel disorderl andl
alcoholl usel disorder?
a)l Methadone
b)l Disulfiram
c)l Naltrexone
d)l Acamprosate
,Answer:
c)l Naltrexone
QUESTION
Al 45-year-oldl womanl withl alcoholl usel disorderl isl admittedl tol thel hospitall withl
confusion,l ataxia,l andl ophthalmoplegia.l Whatl isl thel mostl likelyl diagnosis?
a)l Deliriuml tremens
b)l Wernicke'sl encephalopathy
c)l Korsakoff'sl syndrome
d)l Alcoholl withdrawall seizures
Answer:
(b)l Wernicke'sl encephalopathy
QUESTION
Al 22-year-oldl malel withl severel opioidl usel disorderl isl startedl onl medication-assistedl
treatmentl (MAT).l Whichl medicationl isl mostl appropriatel tol initiatel inl anl outpatientl
setting?
a)l Methadone
b)l Buprenorphine/Naloxone
c)l Naltrexone
d)l Disulfiram
Answer:
b)l Buprenorphine/Naloxone
QUESTION
Al patientl undergoingl opioidl withdrawall isl mostl likelyl tol exhibitl whichl symptom?
a)l Respiratoryl depression
b)l Mydriasis,l piloerection,l andl diarrhea
c)l Sedationl andl hypotension
d)l Bradycardial andl pinpointl pupils
Answer:
(b)l Mydriasis,l piloerection,l andl diarrhea
, QUESTION
Whichl screeningl tooll isl mostl appropriatel forl detectingl hazardousl alcoholl usel inl primaryl
carel settings?
a)l CAGE
b)l PHQ-9
c)l AUDIT-C
d)l GAD-7
Answer:
(c)l AUDIT-C
QUESTION
Whichl ofl thel followingl bestl differentiatesl substancel dependencel froml substancel abusel
inl DSM-5-TRl terminology?
a)l Dependencel isl characterizedl byl continuedl usel despitel negativel consequences,l whilel
abusel isl not.
b)l Dependencel includesl physiologicall withdrawall symptomsl andl tolerance,l whereasl
abusel doesl not.
c)l Therel isl nol distinctionl betweenl dependencel andl abusel inl DSM-5-TR;l theyl arel nowl
classifiedl asl Substancel Usel Disorder.
d)l Abusel involvesl withdrawall symptoms,l whereasl dependencel doesl not.
Answer:
(c)l Therel isl nol distinctionl betweenl dependencel andl abusel inl DSM-5-TR
QUESTION
Whichl neurotransmitterl systeml isl mostl directlyl involvedl inl thel reinforcingl effectsl ofl
substancel use?
a)l Serotonergicl system
b)l Dopaminergicl system
c)l Cholinergicl system
d)l GABAergicl system
Answer:
b)l Dopaminergicl system
QUESTION
